These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25327952)

  • 1. Clinical role of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasia.
    Saguner AM; Ganahl S; Kraus A; Baldinger SH; Medeiros-Domingo A; Saguner AR; Mueller-Burri SA; Wolber T; Haegeli LM; Krasniqi N; Tanner FC; Steffel J; Brunckhorst C; Duru F
    Circ J; 2014; 78(12):2854-61. PubMed ID: 25327952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
    Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment.
    Cardona-Guarache R; Åström-Aneq M; Oesterle A; Asirvatham R; Svetlichnaya J; Marcus GM; Gerstenfeld EP; Klein L; Scheinman MM
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1801-1810. PubMed ID: 31310380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy.
    Bhavnani SP; Coleman CI; White CM; Clyne CA; Yarlagadda R; Guertin D; Kluger J
    Europace; 2008 Jul; 10(7):854-9. PubMed ID: 18495672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia.
    Chu AF; Zado E; Marchlinski FE
    Am J Cardiol; 2010 Sep; 106(5):720-2. PubMed ID: 20723652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Saguner AM; Vecchiati A; Baldinger SH; Rüeger S; Medeiros-Domingo A; Mueller-Burri AS; Haegeli LM; Biaggi P; Manka R; Lüscher TF; Fontaine G; Delacrétaz E; Jenni R; Held L; Brunckhorst C; Duru F; Tanner FC
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):230-9. PubMed ID: 24515411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy.
    Brembilla-Perrot B; Schwartz J; Huttin O; Frikha Z; Sellal JM; Sadoul N; Blangy H; Olivier A; Louis S; Kaminsky P
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):329-35. PubMed ID: 24117873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia.
    Piccini JP; Dalal D; Roguin A; Bomma C; Cheng A; Prakasa K; Dong J; Tichnell C; James C; Russell S; Crosson J; Berger RD; Marine JE; Tomaselli G; Calkins H
    Heart Rhythm; 2005 Nov; 2(11):1188-94. PubMed ID: 16253908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of atrial arrhythmias in patients with ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
    Zado ES; Garg L; Tschabrunn C; Santangeli P; Hyman M; Kumareswaran R; Arkles J; Marchlinski FE
    Heart Rhythm; 2024 Feb; 21(2):133-140. PubMed ID: 37956774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial involvement in arrhythmogenic right ventricular cardiomyopathy patients referred for ventricular arrhythmias ablation.
    Wu L; Bao J; Liang E; Fan S; Zheng L; Du Z; Chen G; Ding L; Zhang S; Yao Y
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1388-1395. PubMed ID: 29897149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Ventricular Repolarization Parameters on Long-Term Risk of Atrial Fibrillation　- Longitudinal Follow-up Data From a General Ambulatory Korean Population.
    Cho MS; Nam GB; Kim YN; Kim J; Choi KJ; Kim YH
    Circ J; 2020 Jun; 84(7):1067-1074. PubMed ID: 32461513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
    De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
    G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of atrial flutter associated with the rejection of heart transplantation.
    Cui G; Tung T; Kobashigawa J; Laks H; Sen L
    Am J Cardiol; 2001 Aug; 88(3):280-4. PubMed ID: 11472708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and Outcomes of Concurrently Diagnosed New Rapid Atrial Fibrillation or Flutter and New Reduced Ejection Fraction.
    Rodriguez Y; Althouse AD; Adelstein EC; Jain SK; Mendenhall GS; Saba S; Shalaby AA; Voigt AH; Wang NC
    Pacing Clin Electrophysiol; 2016 Dec; 39(12):1394-1403. PubMed ID: 27868213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of atrial sensing via a free-floating single-pass defibrillation lead for dual-chamber defibrillators.
    Schuchert A; Niehaus M; Binner L; Belke R; Meinertz T
    J Interv Card Electrophysiol; 2003 Jun; 8(3):209-14. PubMed ID: 12815307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia.
    Saguner AM; Ganahl S; Baldinger SH; Kraus A; Medeiros-Domingo A; Nordbeck S; Saguner AR; Mueller-Burri AS; Haegeli LM; Wolber T; Steffel J; Krasniqi N; Delacrétaz E; Lüscher TF; Held L; Brunckhorst CB; Duru F
    Am J Cardiol; 2014 May; 113(10):1728-34. PubMed ID: 24792740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FUNCTIONAL PARAMETERS OF BLOOD CIRCULATION IN FIRST THREE MONTHS AFTER RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION AND FLUTTER].
    Brynza M; Bilchenko A; Makharynska E; Shevchuk M; Yabluchanskyi N
    Georgian Med News; 2018 Jun; (279):73-79. PubMed ID: 30035725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.